Pulmonx (LUNG) Shares Outstanding (Weighted Average) (2019 - 2025)

Pulmonx (LUNG) has 7 years of Shares Outstanding (Weighted Average) data on file, last reported at $41.7 million in Q4 2025.

• Shares Outstanding (Weighted Average) for Q4 2025 came in at $41.7 million, up 6.55% year-over-year; the trailing twelve-month figure through Dec 2025 was $41.7 million (up 6.55% YoY), and the FY2025 annual result was $41.7 million, up 6.55% from the prior year.
• Shares Outstanding (Weighted Average) grew to $41.7 million in Q4 2025 per LUNG's latest filing, from $40.4 million in the prior quarter.
• Over five years, Shares Outstanding (Weighted Average) peaked at $41.7 million in Q4 2025 and troughed at $35.4 million in Q1 2021.
• A 5-year average of $38.0 million and a median of $37.8 million in 2023 frame the typical range for Shares Outstanding (Weighted Average).
• The sharpest annual moves came in 2021 and 2023: Shares Outstanding (Weighted Average) soared 1594.19% in 2021, then rose 1.63% in 2023.
• A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $36.1 million in 2021, then climbed by 3.1% to $37.2 million in 2022, then advanced by 1.95% to $38.0 million in 2023, then rose by 2.99% to $39.1 million in 2024, then rose by 6.55% to $41.7 million in 2025.
• Business Quant data shows LUNG's Shares Outstanding (Weighted Average) at $41.7 million in Q4 2025, $40.4 million in Q3 2025, and $40.4 million in Q2 2025.